Neogen (NEOG) Expected to Announce Quarterly Earnings on Wednesday

Neogen (NASDAQ:NEOG) is anticipated to post its quarterly earnings results before the market opens on Wednesday, April 9th. Analysts expect Neogen to post earnings of $0.13 per share and revenue of $225.27 million for the quarter. Neogen has set its FY 2025 guidance at EPS.Individual that wish to register for the company’s earnings conference call can do so using this link.

Neogen (NASDAQ:NEOG) last released its quarterly earnings data on Friday, January 10th. The company reported $0.11 earnings per share for the quarter, beating analysts’ consensus estimates of ($0.01) by $0.12. Neogen had a negative net margin of 52.12% and a positive return on equity of 2.89%. The company had revenue of $231.30 million during the quarter, compared to analysts’ expectations of $227.16 million. During the same quarter in the previous year, the company earned $0.11 earnings per share. The firm’s revenue for the quarter was up .7% on a year-over-year basis. On average, analysts expect Neogen to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Neogen Stock Up 0.6 %

Shares of NEOG opened at $7.85 on Tuesday. The stock’s 50 day moving average is $9.72 and its two-hundred day moving average is $12.37. Neogen has a 12 month low of $7.47 and a 12 month high of $18.58. The firm has a market cap of $1.70 billion, a P/E ratio of -3.58 and a beta of 1.57. The company has a current ratio of 3.77, a quick ratio of 2.46 and a debt-to-equity ratio of 0.33.

Analyst Ratings Changes

A number of research firms have recently commented on NEOG. Piper Sandler reissued a “neutral” rating and set a $13.00 target price (down previously from $16.50) on shares of Neogen in a research note on Tuesday, January 21st. Guggenheim began coverage on shares of Neogen in a research note on Thursday, December 19th. They issued a “buy” rating and a $15.00 target price on the stock.

Insiders Place Their Bets

In related news, CEO John Edward Adent purchased 23,035 shares of the company’s stock in a transaction on Thursday, January 16th. The stock was acquired at an average cost of $11.03 per share, for a total transaction of $254,076.05. Following the completion of the transaction, the chief executive officer now directly owns 269,164 shares in the company, valued at approximately $2,968,878.92. The trade was a 9.36 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available at this link. Also, CFO David H. Naemura purchased 14,800 shares of the stock in a transaction dated Thursday, January 16th. The shares were purchased at an average price of $11.11 per share, with a total value of $164,428.00. Following the completion of the transaction, the chief financial officer now owns 61,434 shares of the company’s stock, valued at approximately $682,531.74. This trade represents a 31.74 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 1.13% of the company’s stock.

About Neogen

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.